Celecoxib inhibits acute edema and inflammatory biomarkers through peroxisome proliferator-activated receptor-γ in rats

OBJECTIVE(S): Celecoxib (CLX), a selective cyclooxygenase-II (COX-2) inhibitor, has been used for management of several inflammatory disorders. The present study aimed to explore the role of peroxisome proliferator-activated receptor-gamma (PPARγ) in CLX induced anti-inflammatory response in rats. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Houshmand, Gholamreza, Naghizadeh, Bahareh, Ghorbanzadeh, Behnam, Ghafouri, Zahra, Goudarzi, Mehdi, Mansouri, Mohammad Taghi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811815/
https://www.ncbi.nlm.nih.gov/pubmed/33489027
http://dx.doi.org/10.22038/ijbms.2020.43995.10315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811815/
https://www.ncbi.nlm.nih.gov/pubmed/33489027
http://dx.doi.org/10.22038/ijbms.2020.43995.10315

Ejemplares similares